• About napwha
  • About this site
  • Contact Us
  • Subscribe
  • napwha website
HIV Cure

Find out about current studies

Get Involved
  • Home
  • Science
    • Reservoir, Remission, Rebound
    • Latency Reversing Agents
    • Gene Therapy
    • Vaccines
    • Novel Approaches
    • Research Spotlight
  • Clinical Trials
    • Get Involved
  • Community
  • Media
  • Video

Nic Dorward interviews Professor Sharon Lewin

World AIDS Day COVID and Cure Chat

1 year ago HIV Cure Community Partnership Community, Video

The COVID pandemic has touched everyone, including people living with HIV. Co-founder of The Institute of Many, Nic Dorward, spoke to the new president of the International AIDS Society, Professor Sharon Lewin, in the lead-up to World AIDS Day 2022. They discuss the ongoing importance of a search for an HIV cure. The COVID pandemic…

Brent Allan, Scott Ledger, David Griffin

Managing hope and expectation: Perspectives on HIV cure

1 year ago HIV Cure Community Partnership Latency Reversing Agents, Reservoir, Remission, Rebound

HIV cure. Those two little words elicit such hope, expectation and frustration.  This was the theme that ran through the series of presentations at the HIV and Sexual Health Conference in August 2022 in the session HIV Cure: All in the Mix – Bench, Beside, Community. Scientific HIV cure update After an energising global perspective…

Melissa Churchill, Michael Roche, Catherine Cochrane and Thomas Angelovich

Hidden, but not forgotten: Understanding HIV hiding in the brain

1 year ago HIV Cure Community Partnership Reservoir, Remission, Rebound

Antiretroviral treatment (ART) has significant benefits for the health and quality of life of people with HIV. Despite this, a scalable effective cure remains a difficult challenge. We already know that HIV can hide in blood and tissue cells throughout the body. This virus can stay in a dormant state, capable of reactivation. This latent…

Trust crucial to treatment interruption

1 year ago HIV Cure Community Partnership Research Spotlight

At the Australasian HIV/AIDS Conference, Dr Gordon Campbell discussed participant motivations and experiences from an HIV cure clinical trial with treatment interruption (ATI). Dr Campbell interviewed participants from the TITAN study.  All were satisfied with their experience and most felt well during the study. Trust in the clinical research team was crucial to their participation and peace-of-mind. They…

Gene therapy advance in mice

1 year ago HIV Cure Community Partnership Research Spotlight

A special session at the recent Australasian HIV/AIDS conference featured new research from the Kirby Institute. Dr Scott Ledger presented work on HIV gene therapy in mice. The results show blocking of both virus entry into cells and HIV production. He showed that a single stem cell treatment enabled mice to maintain CD4+ T cell…

All in the mix: bench, bedside, community

1 year ago HIV Cure Community Partnership Community

A terrific session is planned for this year’s joint HIV/AIDS and Sexual Health Conference on the Sunshine Coast. On Tuesday 30th August, a cross-track session will explore the current context, new developments and community experience of HIV cure research. The session will include contributions from diverse panellists from the community, basic science and clinical research,…

Mihiri Weerasuria

Is a cure for HIV on the horizon?

1 year ago HIV Cure Community Partnership Community, Reservoir, Remission, Rebound

A breakdown of the Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 The landscape of HIV care has dramatically shifted over the past few decades. What was once a terminal disease has been transformed by the immense efforts of people with HIV (PWHIV), community groups, researchers, and clinicians into a…

Rachel Pascoe and Youry Kim

Licence to Kill: Pro-apoptotic drugs in “Shock and Kill” HIV cure approach

1 year ago HIV Cure Community Partnership Novel Approaches

A cure to HIV remains elusive. HIV-infected cells survive in the body by avoiding the usual ways the immune system would clear them. By silencing all virus activity, including virus replication and the creation of new proteins, infected cells avoid virus-induced lysis and immune detection. Here is where the approach called ‘shock and kill’ comes…

A roadmap for cure at AIDS 2022

1 year ago HIV Cure Community Partnership Community

The 24th International AIDS Conference takes place in Montréal, Canada and virtually from July 29th- August 2nd 2022. We have compiled a roadmap of events and sessions relating to HIV Cure, including a pre-conference on Pathways to an HIV cure. Thursday July 28  Pathways to an HIV cure: Research and advocacy priorities A 2-day pre-conference…

New sequencing method shows many blood-derived HIV particles are defective

2 years ago HIV Cure Community Partnership Research Spotlight

Sydney researchers have developed a way to sequence near-full-length HIV-genomes from viral particles in the blood. This new test is called the PRLS (plasma-derived RNA using long-range sequencing) assay. The test shows that many HIV particles contain defective genomes and are likely not infectious. Researchers can use the test to identify where the virus comes…

Page 1 of 212»

Inclusion, Respect, Equity: A photo essay of people participating in HIV cure research at The Alfred ...

This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their amazing teams and the people they care for. This article is shared with permission of The Alfred.

Alfred Health

Working together with researchers and clinicians at The Alfred, members of the community of people living with HIV in Victoria have been integral to progressing ...

Trust crucial to treatment interruption

Gene therapy advance in mice

New sequencing method shows many blood-derived HIV particles are defective

High CD4 count before HIV treatment contributes to smaller HIV reservoir on ART

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2012

Supported by


Supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI096109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About NAPWHA

Founded in 1989, The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community-based groups of people living with HIV (PLHIV).
Copyright (c) 2023. National Association of people with HIV Australia. ABN: 79 052 437 899